×

ENTER REPORT NAME TO SEARCH

Global Genome Editing In-Depth Monitoring and Development Analysis Report 2023

Report ID: ARS11521 | Category: Healthcare | Pages: 100 | Format: PDF | Published Date: December 18,2023

Request Sample      Enquiry before buying    Ask For Discount   

Table of Contents

Table of Content

1 Genome Editing  Market Introduction and Overview
1.1 Genome Editing  Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Global Market Growth Trends Analysis
2.1 Global Genome Editing  Market Size & Forecast (2018-2029)
2.2 Genome Editing  Growth Trends Analysis by Regions
2.2.1 Genome Editing  Market Size by Regions: 2018 VS 2023 VS 2029
2.2.2 Genome Editing  Historic Market Size by Regions (2018-2023)
2.2.3 Genome Editing  Forecasted Market Size by Regions (2023-2029)
2.2.4 North America Genome Editing  Market Size & Forecast (2018-2029)
2.2.5 Europe Genome Editing  Market Size & Forecast (2018-2029)
2.2.6 Asia-Pacific Genome Editing  Market Size & Forecast (2018-2029)
2.2.7 Latin America Genome Editing  Market Size & Forecast (2018-2029)
2.2.8 Middle East & Africa Genome Editing  Market Size & Forecast (2018-2029)
3 North America
3.1 North America Genome Editing  Revenue by Countries
3.1.1 North America Genome Editing  Revenue by Countries (2018-2029)
3.2 North America Genome Editing  Revenue by Players
3.3 North America Genome Editing  Revenue by Types
3.4 North America Genome Editing  Revenue by Applications
3.5 United States
3.6 Canada
4 Asia Pacific
4.1 Asia Pacific Genome Editing  Revenue by Countries
4.1.1 Asia Pacific Genome Editing  Revenue by Countries (2018-2029)
4.2 Asia Pacific Genome Editing  Revenue by Players
4.3 Asia Pacific Genome Editing  Revenue by Types
4.4 Asia Pacific Genome Editing  Revenue by Applications
4.5 China
4.6 Japan
4.7 Korea
4.8 Southeast Asia
4.9 India
4.10 Australia
5 Europe
5.1 Europe Genome Editing  Revenue by Countries
5.1.1 Europe Genome Editing  Revenue by Countries (2018-2029)
5.2 Europe Genome Editing  Revenue by Players
5.3 Europe Genome Editing  Revenue by Types
5.4 Europe Genome Editing  Revenue by Applications
5.5 Germany
5.6 France
5.7 UK
5.8 Italy
5.9 Russia
5.10 Spain
5.11 Nordic
6 Latin America
6.1 Latin America Genome Editing  Revenue by Countries
6.1.1 Latin America Genome Editing  Revenue by Countries (2018-2029)
6.2 Latin America Genome Editing  Revenue by Players
6.3 Latin America Genome Editing  Revenue by Types
6.4 Latin America Genome Editing  Revenue by Applications
6.5 Brazil
6.6 Argentina
6.7 Colombia
6.8 Mexico
7 Middle East & Africa
7.1 Middle East & Africa Genome Editing  Revenue by Countries
7.1.1 Middle East & Africa Genome Editing  Revenue by Countries (2018-2029)
7.2 Middle East & Africa Genome Editing  Revenue by Players
7.3 Middle East & Africa Genome Editing  Revenue by Types
7.4 Middle East & Africa Genome Editing  Revenue by Applications
7.5 Egypt
7.6 South Africa
7.7 Israel
7.8 Turkey
7.9 GCC Countries
8 Global Genome Editing  Historical and Forecast Market Analysis by Type
8.1 Global Genome Editing  Revenue and Market Share by Type
8.2 Global Genome Editing  Market Forecast by Type (2023-2029)
9 Global Genome Editing  Historical and Forecast Market Analysis by Application
9.1 Global Genome Editing  Revenue Market Share by Application (2018-2023)
9.2 Genome Editing  Market Forecast by Application (2023-2029)
10 Genome Editing  Industry Dynamic Analysis
10.1 Genome Editing  Market Trends Analysis
10.2 Genome Editing  Market Drivers Analysis
10.3 Genome Editing  Market Challenges Analysis
10.4 Genome Editing  Market Restraints Analysis
10.5 Genome Editing  Industry Mergers & Acquisitions
10.6 Genome Editing  Industry New Entrants and Expansion Plans
11 Players Profiles
11.1  Merck KGaA (Germany)
11.1.1 Merck KGaA (Germany) Company Profile
11.1.2 Genome Editing  Product Overview
11.1.3 Merck KGaA (Germany) Genome Editing  Market Performance (2018-2023)
11.1.4 Merck KGaA (Germany) Business Overview
11.2  GenScript (China)
11.2.1 GenScript (China) Company Profile
11.2.2 Genome Editing  Product Overview
11.2.3 GenScript (China) Genome Editing  Market Performance (2018-2023)
11.2.4 GenScript (China) Business Overview
11.3  Sangamo Therapeutics (U.S.)
11.3.1 Sangamo Therapeutics (U.S.) Company Profile
11.3.2 Genome Editing  Product Overview
11.3.3 Sangamo Therapeutics (U.S.) Genome Editing  Market Performance (2018-2023)
11.3.4 Sangamo Therapeutics (U.S.) Business Overview
11.4  Lonza (Switzerland)
11.4.1 Lonza (Switzerland) Company Profile
11.4.2 Genome Editing  Product Overview
11.4.3 Lonza (Switzerland) Genome Editing  Market Performance (2018-2023)
11.4.4 Lonza (Switzerland) Business Overview
11.5  Editas Medicine (U.S.)
11.5.1 Editas Medicine (U.S.) Company Profile
11.5.2 Genome Editing  Product Overview
11.5.3 Editas Medicine (U.S.) Genome Editing  Market Performance (2018-2023)
11.5.4 Editas Medicine (U.S.) Business Overview
11.6  CRISPR Therapeutics (Switzerland)
11.6.1 CRISPR Therapeutics (Switzerland) Company Profile
11.6.2 Genome Editing  Product Overview
11.6.3 CRISPR Therapeutics (Switzerland) Genome Editing  Market Performance (2018-2023)
11.6.4 CRISPR Therapeutics (Switzerland) Business Overview
11.7  Tecan Trading AG (Switzerland)
11.7.1 Tecan Trading AG (Switzerland) Company Profile
11.7.2 Genome Editing  Product Overview
11.7.3 Tecan Trading AG (Switzerland) Genome Editing  Market Performance (2018-2023)
11.7.4 Tecan Trading AG (Switzerland) Business Overview
11.8  Precision Biosciences (U.S.)
11.8.1 Precision Biosciences (U.S.) Company Profile
11.8.2 Genome Editing  Product Overview
11.8.3 Precision Biosciences (U.S.) Genome Editing  Market Performance (2018-2023)
11.8.4 Precision Biosciences (U.S.) Business Overview
11.9  PerkinElmer Inc. (U.S.)
11.9.1 PerkinElmer Inc. (U.S.) Company Profile
11.9.2 Genome Editing  Product Overview
11.9.3 PerkinElmer Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
11.9.4 PerkinElmer Inc. (U.S.) Business Overview
11.10  Cellectis S.A (France)
11.10.1 Cellectis S.A (France) Company Profile
11.10.2 Genome Editing  Product Overview
11.10.3 Cellectis S.A (France) Genome Editing  Market Performance (2018-2023)
11.10.4 Cellectis S.A (France) Business Overview
11.11  Genome Medical, Inc. (U.S.)
11.11.1 Genome Medical, Inc. (U.S.) Company Profile
11.11.2 Genome Editing  Product Overview
11.11.3 Genome Medical, Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
11.11.4 Genome Medical, Inc. (U.S.) Business Overview
11.12  BioMed Central Ltd (U.K.)
11.12.1 BioMed Central Ltd (U.K.) Company Profile
11.12.2 Genome Editing  Product Overview
11.12.3 BioMed Central Ltd (U.K.) Genome Editing  Market Performance (2018-2023)
11.12.4 BioMed Central Ltd (U.K.) Business Overview
11.13  Aevi Genomic Medicine, Inc. (Israel)
11.13.1 Aevi Genomic Medicine, Inc. (Israel) Company Profile
11.13.2 Genome Editing  Product Overview
11.13.3 Aevi Genomic Medicine, Inc. (Israel) Genome Editing  Market Performance (2018-2023)
11.13.4 Aevi Genomic Medicine, Inc. (Israel) Business Overview
11.14  Congenica Ltd. (U.K.)
11.14.1 Congenica Ltd. (U.K.) Company Profile
11.14.2 Genome Editing  Product Overview
11.14.3 Congenica Ltd. (U.K.) Genome Editing  Market Performance (2018-2023)
11.14.4 Congenica Ltd. (U.K.) Business Overview
11.15  Deep Genomics (Canada)
11.15.1 Deep Genomics (Canada) Company Profile
11.15.2 Genome Editing  Product Overview
11.15.3 Deep Genomics (Canada) Genome Editing  Market Performance (2018-2023)
11.15.4 Deep Genomics (Canada) Business Overview
11.16  Editas Medicine (U.S.)
11.16.1 Editas Medicine (U.S.) Company Profile
11.16.2 Genome Editing  Product Overview
11.16.3 Editas Medicine (U.S.) Genome Editing  Market Performance (2018-2023)
11.16.4 Editas Medicine (U.S.) Business Overview
11.17  Illumina, Inc. (U.S.)
11.17.1 Illumina, Inc. (U.S.) Company Profile
11.17.2 Genome Editing  Product Overview
11.17.3 Illumina, Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
11.17.4 Illumina, Inc. (U.S.) Business Overview
11.18  Thermo Fisher Scientific Inc. (U.S.)
11.18.1 Thermo Fisher Scientific Inc. (U.S.) Company Profile
11.18.2 Genome Editing  Product Overview
11.18.3 Thermo Fisher Scientific Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
11.18.4 Thermo Fisher Scientific Inc. (U.S.) Business Overview
11.19  QIAGEN N.V. (Netherlands)
11.19.1 QIAGEN N.V. (Netherlands) Company Profile
11.19.2 Genome Editing  Product Overview
11.19.3 QIAGEN N.V. (Netherlands) Genome Editing  Market Performance (2018-2023)
11.19.4 QIAGEN N.V. (Netherlands) Business Overview
11.20  Agilent Technologies, Inc. (U.S.)
11.20.1 Agilent Technologies, Inc. (U.S.) Company Profile
11.20.2 Genome Editing  Product Overview
11.20.3 Agilent Technologies, Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
11.20.4 Agilent Technologies, Inc. (U.S.) Business Overview
11.21  Bio-Rad Laboratories, Inc. (U.S.)
11.21.1 Bio-Rad Laboratories, Inc. (U.S.) Company Profile
11.21.2 Genome Editing  Product Overview
11.21.3 Bio-Rad Laboratories, Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
11.21.4 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
12 Research Findings and Conclusion

FAQ's

It contains all the geographic trends, and market analysis for global market